- Home
- DXR vs MDCX Comparison
DXR vs MDCX Comparison
Compare DXR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- MDCX
- Stock Information
- Founded
- DXR 1970
- MDCX 2008
- Country
- DXR United States
- MDCX Canada
- Employees
- DXR N/A
- MDCX N/A
- Industry
- DXR Medical/Dental Instruments
- MDCX
- Sector
- DXR Health Care
- MDCX
- Exchange
- DXR Nasdaq
- MDCX Nasdaq
- Market Cap
- DXR 37.6M
- MDCX 33.8M
- IPO Year
- DXR N/A
- MDCX N/A
- Fundamental
- Price
- DXR $7.24
- MDCX $4.00
- Analyst Decision
- DXR Strong Buy
- MDCX Strong Buy
- Analyst Count
- DXR 1
- MDCX 1
- Target Price
- DXR $24.75
- MDCX $10.00
- AVG Volume (30 Days)
- DXR 5.7K
- MDCX 42.7K
- Earning Date
- DXR 01-01-0001
- MDCX 01-01-0001
- Dividend Yield
- DXR N/A
- MDCX N/A
- EPS Growth
- DXR N/A
- MDCX N/A
- EPS
- DXR 0.35
- MDCX N/A
- Revenue
- DXR $154,205.00
- MDCX N/A
- Revenue This Year
- DXR N/A
- MDCX N/A
- Revenue Next Year
- DXR N/A
- MDCX N/A
- P/E Ratio
- DXR $20.78
- MDCX N/A
- Revenue Growth
- DXR N/A
- MDCX N/A
- 52 Week Low
- DXR $6.55
- MDCX $1.80
- 52 Week High
- DXR $10.00
- MDCX $4.39
- Technical
- Relative Strength Index (RSI)
- DXR 37.76
- MDCX N/A
- Support Level
- DXR $7.00
- MDCX N/A
- Resistance Level
- DXR $7.49
- MDCX N/A
- Average True Range (ATR)
- DXR 0.33
- MDCX 0.00
- MACD
- DXR -0.01
- MDCX 0.00
- Stochastic Oscillator
- DXR 44.44
- MDCX 0.00
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.